SecBot SecBot
8-K ·Filed Oct 28, 2026

ENTA

ENANTA PHARMACEUTICALS INC
NEUTRAL
Impact 3/10
Processed59m ago SEC0001193125-26-435092
8-K context-dependent: Items 5.02, 7.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-435092
Document: d160214dex991.htm0001193125-26-435092
Document: 0001193125-26-435092-index-headers.html0001193125-26-435092
Document: 0001193125-26-435092-index.html0001193125-26-435092
Document: 0001193125-26-435092.txt0001193125-26-435092
3 reports for ENTA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ENTA, sortable and filterable
TypeNow
Oct 28, 2026
today
8-K
NEUTRAL ★ 3/10
$11.98awaiting T+20awaiting T+20$12.18 (+1.67%)
Oct 27, 2026
today
SC 13G
NEUTRAL ★ 4/10
$12.06awaiting T+20awaiting T+20$12.18 (+1.00%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 7/10
$13.52 $13.24▼ −2.07%▼ −1.01%$12.18 (−9.91%)
Showing 3 of 3

US Market Status

Market Closed · Opens in 1h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 28, 2026

Fresh ENTA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access